For some cancers, such as chronic myeloid leukemia (CML), the pathogenic BCR/ABL protein is located inside the cell, and antibodies could not penetrate the cell membrane to achieve the purpose of treatment. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.